TGFB1 and cancer: CD109 is a glycosylphosphatidylinositol-anchored protein that negatively regulates Transforming Growth Factor-β (TGF-β) signaling, thereby influencing cytokine secretion, immune cell recruitment, and macrophage polarization, with profound effects on the TME and cancer cell phenotype (17).